Sat.Oct 12, 2024 - Fri.Oct 18, 2024

article thumbnail

Is it time to freak out about bird flu?

STAT

If you’re aware of the H5N1 bird flu outbreak in U.S. dairy cattle — you may have seen some headlines or read something on social media — perhaps you are wondering what the fuss is about. Yes, there have been nearly a couple dozen human cases, but all have had mild symptoms. The virus does not decimate herds in the way it does poultry flocks; most — though not all — of the infected cows come through the illness OK.

364
364
article thumbnail

Want to launch a blockbuster? An AstraZeneca exec breaks it down.

PharmaVoice

Even drugs with “blockbuster potential” often fall short of expectations. Here’s what can help a new medication pass the $1 billion mark.

288
288
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wave sees RNA editing validation in early trial results

BioPharma Dive

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.

article thumbnail

Women in more deprived areas half as likely to access HRT, data shows

The Pharmacist

Women in deprived areas are accessing hormone replacement therapy (HRT) on the NHS at nearly half the rate of women in more affluent areas, the latest data shows. According to analysis by The Pharmacist, just 10% of women aged 45-59 living in the 20% most deprived areas in England were given HRT on the NHS in […] The post Women in more deprived areas half as likely to access HRT, data shows appeared first on The Pharmacist.

134
134
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Chickenpox, shingles, Alzheimer’s? Evidence mounts for a viral cause of dementia

STAT

Pascal Geldsetzer believes in open access, in disseminating science as quickly as it happens. Even so, last summer, as he uploaded the surprising results of his latest study to the MedRxiv preprint server, the Stanford University epidemiologist was feeling something other than the usual excitement. “I was scared to put this up because it’s such a different approach from what’s generally done in epidemiology and medicine,” he said.

363
363
article thumbnail

AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential

PharmaVoice

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

More Trending

article thumbnail

After rejections, AbbVie secures approval for Parkinson’s drug

BioPharma Dive

Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.

133
133
article thumbnail

STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows

STAT

The nation’s three largest Medicare Advantage insurers increasingly refused to pay for rehabilitative care for seniors in the years after adopting sophisticated technologies to aid in their coverage decisions, a Senate investigation found. UnitedHealth Group, Humana, and CVS Health targeted denials among older adults who were requesting care in nursing homes, inpatient rehab hospitals, and long-term hospitals.

article thumbnail

Wave sees RNA editing validation in early trial results

PharmaVoice

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.

article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

In August 2024, the European Commission approved EURneffy (adrenaline nasal spray) in the EU as the first needle-free emergency option to treat anaphylaxis. This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). What are the main advantages of EURneffy over similar treatments? EURneffy was determined by the European Medicines Agency (EMA) to be interchangeable with injection products given it provides the comparable exposures to epinephrine (adren

121
121
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

India will transform into a global biomanufacturing hub: Dr Jitendra Singh

Express Pharma

Union Minister of State for Science and Technology (Independent Charge) Dr. Jitendra Singh today said that India will be transformed into a science and technology-driven global biomanufacturing hub. The Minister was speaking after inaugurating the CSIR-NIIST Golden Jubilee celebrations and Milestone Observation Program at CSIR-NIIST campus, Thiruvananthapuram.

119
119
article thumbnail

STAT+: Inside UnitedHealth’s strategy to pressure physicians: $10,000 bonuses and a doctor leaderboard

STAT

The emails from UnitedHealth Group managers were filled with exclamation marks and pleasantries about the weather. But the underlying message to doctors in late 2020 was persistent and urgent: Hit your targets to see more patients. We need to bring in more money. At the time, deaths from Covid-19 were surging, and no vaccine was available.

article thumbnail

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

PharmaVoice

Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies will look in the future.

183
183
article thumbnail

Sanofi invests €300m in Orano Med's lead-based radioligands

pharmaphorum

Sanofi invests €300m in Orano Med's lead-based radioligandsSanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear fuel company Orano.The transaction builds on a three-way partnership between Sanofi, Orano Med, and RadioMedix – signed in September with a €100 million upfront payment – to develop a radioligand therapy (RLT) for rare neuroendocrine tumours (NETs) c

119
119
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Nearly 60,000 HRT items supplied under SSPs last year

The Pharmacist

Nearly 60,000 hormone replacement therapy (HRT) items were supplied under a serious shortage protocol (SSP) in England last year, new data has revealed. And more than 13 million HRT items were supplied overall in England last year, according to the latest figures from the NHS Business Services Authority (NHSBSA). HRT shortages increase sixfold in a […] The post Nearly 60,000 HRT items supplied under SSPs last year appeared first on The Pharmacist.

123
123
article thumbnail

In children, Covid is tied to higher risk of type 2 diabetes 

STAT

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.  An observational study published Monday in JAMA Network Open found that children and adolescents were one-and-a-half times more likely to be diagnosed with the metabolic disorder in the months after having Covid-19 compared to similar kids who weathered other respiratory infections.

Diabetes 363
article thumbnail

2024 PharmaVoice 100s: Standout Leaders

PharmaVoice

Long-time executives with a strong track record of advancing drug R&D, business savvy strategies and leadership in various sectors of pharma.

254
254
article thumbnail

Lilly pledges £279m to UK for biotech hub and obesity plan

pharmaphorum

Eli Lilly may invest $364m in the UK and work with the government to tackle serious public health challenges including obesity.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Taiwo Owatemi: 'MPs aren't hearing enough about pharmacy'

The Pharmacist

Pharmacists must raise concerns with their local MPs about the issues they are facing, the Labour MP for Coventry North West and government whip Taiwo Owatemi has urged. Ms Owatemi, who is herself a pharmacist, said the profession needed to speak with a unified voice, be more vocal about concerns and collaborate with other professions. […] The post Taiwo Owatemi: 'MPs aren't hearing enough about pharmacy' appeared first on The Pharmacist.

118
118
article thumbnail

130,000 U.S. cancer cases went undiagnosed in Covid pandemic, study finds

STAT

When the U.S. health care system pivoted to meet Covid-19 in 2020, routine health visits and screenings where many cancer cases would have been caught didn’t happen. It wasn’t ideal, but many health experts thought that as the country opened back up, screenings would help “catch up” to these missed cases. A new paper published Monday in JAMA Network Open suggests that didn’t happen as quickly as experts had hoped.

363
363
article thumbnail

Clinical staff that feel like ‘tech support’ — and other issues a CRO exec contends with

PharmaVoice

From tech-related challenges to an ongoing staffing crunch, Parexel’s CEO explains what the clinical trials industry is up against.

163
163
article thumbnail

Baxter medicines in short supply after hurricane hits plant

pharmaphorum

Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.The plant in North Cove, North Carolina, was severely affected by flooding and had to be shut down at the end of September. It is Baxter's biggest manufacturing site and is also the largest supplier of intravenous and peritoneal dialysis solutions to the US market.

116
116
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FDA, facing pressure, to review position on Zepbound, Mounjaro shortage

BioPharma Dive

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in supply.

article thumbnail

STAT+: How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

STAT

In the last two years, telehealth has gone all in on GLP-1s. Dozens of companies have started to offer the wildly popular obesity and diabetes medications, meeting patients who are flooding online for prescriptions that could help them lose as much as 20% of their body weight.  The telehealth GLP-1 boom wouldn’t be possible without clinicians willing to write prescriptions for those hundreds of thousands of patients.

article thumbnail

Unique drug delivery method may improve treatment of brain tuberculosis

Express Pharma

Researchers at the Institute of Nano Science and Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology have created a unique way to deliver Tuberculosis medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines. This innovative drug delivery method can potentially treat brain TB.

105
105
article thumbnail

Pfizer rounds out haemophilia portfolio with FDA approval

pharmaphorum

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year.Marstacimab will be launched as Hympavzi to treat haemophilia A without factor VIII inhibitors and haemophilia B without factor IX inhibitors in patients aged 12 and older and is the first drug in the anti-TFPI class to be approved in the US.

111
111
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Sage to cut one-third of workforce, streamline drug pipeline

BioPharma Dive

The restructuring, which follows clinical setbacks in Alzheimer’s, Parkinson’s and tremor, will also involve the departure of five senior executives.

115
115
article thumbnail

UnitedHealthcare rolls out new therapy restrictions for Medicare Advantage plans

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up  to get it in your inbox every Monday. Hello, you spry bunch. We’re coming to you on a Tuesday after yesterday’s holiday. What are you looking to read more about as the year winds down? Let us know: bob.herman@statnews.com.

article thumbnail

Researchers develop new method to deliver TB drugs directly to the brain

Express Pharma

Researchers have developed a new method to deliver Tuberculosis (TB) medicines directly to the brain, bypassing the blood-brain barrier (BBB), a protective barrier that limits the effectiveness of traditional treatments for brain TB. This method, designed to treat Central Nervous System Tuberculosis (CNS-TB), has the potential to significantly improve outcomes for this life-threatening condition.

105
105
article thumbnail

MSD preparing to take on Beyfortus with RSV antibody

pharmaphorum

MSD reveals the data that could unlock filings for clesrovimab, a rival to Sanofi and AstraZeneca's Beyfortus for preventing infant RSV infections

116
116
article thumbnail

FDA puts Novavax flu vaccine trials on hold

BioPharma Dive

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

Vaccines 110